These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10887108

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM, Hu PP, Shen X, Yu Y, Wang XF.
    Proc Natl Acad Sci U S A; 1997 May 13; 94(10):4948-53. PubMed ID: 9144170
    [Abstract] [Full Text] [Related]

  • 3. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA.
    Oncogene; 1998 Aug 20; 17(7):867-76. PubMed ID: 9780003
    [Abstract] [Full Text] [Related]

  • 4. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10699-704. PubMed ID: 9380698
    [Abstract] [Full Text] [Related]

  • 5. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K, Vlach J, Hennecke S, Amati B.
    EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992
    [Abstract] [Full Text] [Related]

  • 6. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ, Jones NC.
    Curr Biol; 1996 Apr 01; 6(4):474-83. PubMed ID: 8723352
    [Abstract] [Full Text] [Related]

  • 7. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW.
    Cell Growth Differ; 1998 Jan 01; 9(1):59-69. PubMed ID: 9438389
    [Abstract] [Full Text] [Related]

  • 8. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE.
    Exp Cell Res; 1999 Dec 15; 253(2):561-72. PubMed ID: 10585280
    [Abstract] [Full Text] [Related]

  • 9. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L.
    Oncogene; 2001 Sep 27; 20(43):6205-14. PubMed ID: 11593429
    [Abstract] [Full Text] [Related]

  • 10. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 11. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL.
    Cancer Gene Ther; 1999 Mar 20; 6(2):163-71. PubMed ID: 10195883
    [Abstract] [Full Text] [Related]

  • 13. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):4350-4. PubMed ID: 8633069
    [Abstract] [Full Text] [Related]

  • 15. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
    Bandyopadhyay D, Medrano EE.
    Ann N Y Acad Sci; 2000 Jun 30; 908():71-84. PubMed ID: 10911949
    [Abstract] [Full Text] [Related]

  • 16. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M, Hengstschläger-Ottnad E, Pusch O, Wawra E.
    Oncogene; 1996 Apr 18; 12(8):1635-43. PubMed ID: 8622883
    [Abstract] [Full Text] [Related]

  • 17. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia.
    Gibbs JD, Liebermann DA, Hoffman B.
    Oncogene; 2008 Jan 03; 27(1):98-106. PubMed ID: 17599039
    [Abstract] [Full Text] [Related]

  • 18. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R, Cheng E, Smicun Y, Germino J.
    J Exp Med; 2000 Mar 20; 191(6):1005-16. PubMed ID: 10727462
    [Abstract] [Full Text] [Related]

  • 19. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
    Amanullah A, Liebermann DA, Hoffman B.
    Oncogene; 2000 Jun 15; 19(26):2967-77. PubMed ID: 10871848
    [Abstract] [Full Text] [Related]

  • 20. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.
    Cancer Radiother; 2001 Apr 15; 5(2):109-29. PubMed ID: 11355576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.